$CNMD The Russell 2000 weakness is a reminder that a cheap-looking chart isn't a catalyst. Watching volume and the next company update.
What are you watching on this one?
$CVGW Quick small-cap note: A strong balance sheet can be a real advantage when capital gets expensive.
I’m keeping an eye on margins, cash burn, and management’s capital discipline.
That’s the difference between a story and an investable thesis.
$ABSI AI enthusiasm still has to clear a biological validation test.
For Absci, customer evidence and cash discipline would do more for conviction than a stronger technology index.
Breaking AH:
$GCTK
Glucotrack has completed its strategic merger with Lkahi Therapeutics, establishing a publicly traded company controlled by Lkahi
Worth keeping on the radar
Pre-Market Watch:
$KEEL
is trying to build a base after last week's sharp selloff. Buyers have defended the recent lows, but the stock still needs a higher high to signal that momentum is shifting.
74 Followers 123 Following⚡ Technology, energy & everyday Europe
EVs · Batteries · AI · Life in Germany
Curious by nature. Engineer by training.
EN / DE / 中文